As of Nov 17
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 15.00, with a high estimate of 25.00 and a low estimate of 14.00. The median estimate represents a -6.07% decrease from the last price of 15.97.
The current consensus among 8 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.